"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 2 | 5 |
| 2004 | 3 | 3 | 6 |
| 2005 | 7 | 2 | 9 |
| 2006 | 7 | 1 | 8 |
| 2007 | 4 | 3 | 7 |
| 2008 | 9 | 2 | 11 |
| 2009 | 5 | 2 | 7 |
| 2010 | 13 | 2 | 15 |
| 2011 | 10 | 3 | 13 |
| 2012 | 11 | 1 | 12 |
| 2013 | 22 | 3 | 25 |
| 2014 | 20 | 1 | 21 |
| 2015 | 17 | 2 | 19 |
| 2016 | 42 | 7 | 49 |
| 2017 | 568 | 136 | 704 |
| 2018 | 564 | 113 | 677 |
| 2019 | 256 | 65 | 321 |
| 2020 | 256 | 38 | 294 |
| 2021 | 187 | 21 | 208 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies. Haematologica. 2022 03 01; 107(3):572-573.
-
COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns? J Natl Cancer Inst. 2022 02 07; 114(2):169-171.
-
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients. J Natl Cancer Inst. 2022 Feb 07; 114(2):203-209.
-
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience. J Infect Dis. 2022 01 18; 225(2):352-354.
-
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer. JAMA Oncol. 2021 11 01; 7(11):1686-1691.
-
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease. JAMA Oncol. 2021 11 01; 7(11):1714-1716.
-
Diagnostic impact of safety protocols for processing peritoneal washing specimens during the global pandemic of coronavirus disease 2019: A comparative study from 195 cytological samples. Cytopathology. 2022 01; 33(1):93-99.
-
Use of an Analytics and Electronic Health Record-Based Approach for Targeted COVID-19 Vaccine Outreach to Marginalized Populations. JAMA Oncol. 2021 10 01; 7(10):1570-1572.
-
Impact of the COVID-19 pandemic on population-based cancer registry. Int J Cancer. 2022 01 15; 150(2):273-278.
-
Ongoing research examines COVID-19 vaccination effectiveness in patients with cancer and survivors. Cancer. 2021 09 15; 127(18):3281.